Ministries Agree To Require MNC Acquisitions To Meet Indian Drug Needs
This article was originally published in PharmAsia News
Several Indian ministries joined to protect the interests of Indians relying on essential drugs by making their needs part of the process of approving multinational pharmaceutical company acquisitions of India-based firms.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.